MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Integra LifeSciences Holdings Corporation Total Liabilities 2011-2026 | IART
Annual Total Liabilities Integra LifeSciences Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.49 B | 2.19 B | 2.09 B | 2.1 B | 2.1 B | 1.89 B | 1.73 B | 2.25 B | 968 M | 1.02 B | 874 M | 526 M | 646 M | 651 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.49 B | 526 M | 1.54 B |
Quarterly Total Liabilities Integra LifeSciences Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.63 B | 2.53 B | 2.54 B | 2.54 B | 2.48 B | 2.16 B | 2.09 B | 2.07 B | 2.09 B | 2.08 B | - | 2.06 B | 2.1 B | 2.14 B | 2.14 B | 2.21 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 1.89 B | 1.89 B | 1.89 B | 1.89 B | 1.73 B | 1.73 B | 1.73 B | 1.73 B | 2.25 B | 2.25 B | 2.25 B | 2.25 B | 968 M | 968 M | 968 M | 968 M | 1.02 B | 1.02 B | 1.02 B | 1.02 B | 883 M | 883 M | 874 M | 874 M | 526 M | 526 M | 526 M | 526 M | 646 M | 646 M | 646 M | 646 M | 651 M | 656 M | 656 M | 656 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.63 B | 526 M | 1.54 B |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
2.24 M | $ 2.24 | 0.9 % | $ 3.5 M |  USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 10.47 | 0.19 % | $ 1.41 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 12.56 | -3.75 % | $ 1.88 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
69.7 M | $ 9.61 | -13.93 % | $ 272 M | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
281 M | $ 8.37 | 0.12 % | $ 601 M |  Israel |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Butterfly Network
BFLY
|
87.2 M | $ 3.95 | -7.49 % | $ 836 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.65 | -4.41 % | $ 35.4 M | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 71.28 | 0.11 % | $ 106 B | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 3.92 | -3.21 % | $ 146 M |  France |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 36.71 | -1.69 % | $ 1.14 B | USA |
 |
Establishment Labs Holdings
ESTA
|
334 M | $ 65.5 | 0.75 % | $ 1.94 B |  Costa-rica |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
53.1 M | $ 18.44 | -0.05 % | $ 121 M | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
InMode Ltd.
INMD
|
83.2 M | $ 13.45 | -1.47 % | $ 869 M | Israel |
 |
Abbott Laboratories
ABT
|
36.6 B | $ 108.49 | -2.04 % | $ 189 B | USA |
 |
IRIDEX Corporation
IRIX
|
24.9 M | $ 1.33 | - | $ 21.5 M | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 9.38 | -3.7 % | $ 336 M | USA |
 |
Bio-Rad Laboratories
BIO
|
2.79 B | $ 267.99 | -0.55 % | $ 7.56 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 16.66 | -3.2 % | $ 391 M | USA |
 |
Helius Medical Technologies
HSDT
|
5.34 M | $ 2.07 | -4.61 % | $ 1.26 M | USA |
 |
AxoGen
AXGN
|
92.8 M | $ 30.94 | -5.53 % | $ 1.42 B | USA |
 |
Align Technology
ALGN
|
2.36 B | $ 172.41 | -2.11 % | $ 12.9 B | USA |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 34.03 | 0.86 % | $ 5.07 K | USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
52 M | $ 3.67 | -1.87 % | $ 151 M | USA |
 |
Second Sight Medical Products
EYES
|
24 M | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
389 M | $ 0.41 | 5.24 % | $ 42.1 M | USA |
 |
IRadimed Corporation
IRMD
|
14.2 M | $ 99.67 | -3.04 % | $ 1.27 B | USA |